Ocular Therapeutix (OCUL) Amortization of Deferred Charges (2013 - 2026)
Ocular Therapeutix's quarterly Amortization of Deferred Charges came in at $1.4 million in Q1 2026, down 3.83% year-on-year from $1.4 million in Q1 2025, and up 178.99% quarter-over-quarter from $495000.0 in Q4 2025.
Ocular Therapeutix has reported Amortization of Deferred Charges for 14 years, with the latest figure at $1.4 million in Q1 2026.
- For the quarter ending Q1 2026, Amortization of Deferred Charges fell 3.83% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $3.3 million (up 4.37% YoY), and the FY2025 full-year result was $3.4 million, down 9.03% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $1.4 million, up from $495000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $2.1 million in Q3 2023, with the low at $495000.0 in Q4 2025.
- Average Amortization of Deferred Charges over 5 years is $1.1 million, with a median of $1.2 million recorded in 2022.
- Year-over-year, Amortization of Deferred Charges surged 69.14% in 2023 and tumbled 70.03% in 2024.
- Tracing OCUL's Amortization of Deferred Charges over 5 years: stood at $1.2 million in 2022, then climbed by 25.55% to $1.6 million in 2023, then sank by 62.91% to $576000.0 in 2024, then dropped by 14.06% to $495000.0 in 2025, then surged by 178.99% to $1.4 million in 2026.
- The last three Amortization of Deferred Charges figures came in at $1.4 million (Q1 2026), $495000.0 (Q4 2025), and $758000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.38 Mn |
| Mar 31, 2026 | 1.38 Mn |
| Dec 31, 2025 | 495,000.00 |
| Dec 31, 2025 | 495,000.00 |
| Sep 30, 2025 | 758,000.00 |
| Sep 30, 2025 | 758,000.00 |
| Jun 30, 2025 | 708,000.00 |
| Jun 30, 2025 | 708,000.00 |
| Mar 31, 2025 | 1.44 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Dec 31, 2024 | 576,000.00 |
| Dec 31, 2024 | 576,000.00 |
| Sep 30, 2024 | 621,000.00 |
| Sep 30, 2024 | 621,000.00 |
| Jun 30, 2024 | 569,000.00 |
| Jun 30, 2024 | 569,000.00 |
| Mar 31, 2024 | 1.97 Mn |
| Mar 31, 2024 | 1.97 Mn |
| Dec 31, 2023 | 1.55 Mn |
| Dec 31, 2023 | 1.55 Mn |
| Sep 30, 2023 | 2.07 Mn |
| Sep 30, 2023 | 2.07 Mn |
| Jun 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 1.25 Mn |
| Mar 31, 2023 | 1.23 Mn |
| Mar 31, 2023 | 1.23 Mn |
| Dec 31, 2022 | 1.24 Mn |
| Dec 31, 2022 | 1.24 Mn |
| Sep 30, 2022 | 1.23 Mn |
| Sep 30, 2022 | 1.23 Mn |
| Jun 30, 2022 | 1.21 Mn |
| Jun 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | 1.19 Mn |
| Mar 31, 2022 | 1.19 Mn |
| Dec 31, 2021 | 1.19 Mn |
| Dec 31, 2021 | 1.19 Mn |
| Sep 30, 2021 | 1.16 Mn |
| Sep 30, 2021 | 1.16 Mn |
| Jun 30, 2021 | 1.15 Mn |
| Jun 30, 2021 | 1.15 Mn |
| Mar 31, 2021 | 1.13 Mn |
| Mar 31, 2021 | 1.13 Mn |
| Dec 31, 2020 | 1.14 Mn |
| Dec 31, 2020 | 1.14 Mn |
| Sep 30, 2020 | 1.12 Mn |
| Sep 30, 2020 | 1.12 Mn |
| Jun 30, 2020 | 1.11 Mn |
| Jun 30, 2020 | 1.11 Mn |
| Mar 31, 2020 | 1.05 Mn |
| Mar 31, 2020 | 1.05 Mn |
| Dec 31, 2019 | 1.21 Mn |
| Dec 31, 2019 | 1.21 Mn |
| Sep 30, 2019 | 1.05 Mn |
| Sep 30, 2019 | 1.05 Mn |
| Jun 30, 2019 | 1.23 Mn |
| Jun 30, 2019 | 1.23 Mn |
| Mar 31, 2019 | 187,000.00 |
| Mar 31, 2019 | 187,000.00 |
| Dec 31, 2018 | 132,000.00 |
| Dec 31, 2018 | 132,000.00 |
| Sep 30, 2018 | 80,000.00 |
| Sep 30, 2018 | 80,000.00 |
| Jun 30, 2018 | 87,000.00 |
| Jun 30, 2018 | 87,000.00 |
| Mar 31, 2018 | 98,000.00 |
| Mar 31, 2018 | 98,000.00 |
| Dec 31, 2017 | 99,000.00 |
| Dec 31, 2017 | 99,000.00 |
| Sep 30, 2017 | 99,000.00 |
| Sep 30, 2017 | 99,000.00 |
| Jun 30, 2017 | 100,000.00 |
| Jun 30, 2017 | 100,000.00 |
| Mar 31, 2017 | 110,000.00 |
| Mar 31, 2017 | 110,000.00 |
| Dec 31, 2016 | 265,000.00 |
| Dec 31, 2016 | 265,000.00 |
| Sep 30, 2016 | 35,000.00 |
| Sep 30, 2016 | 35,000.00 |
| Jun 30, 2016 | 36,000.00 |
| Jun 30, 2016 | 36,000.00 |
| Mar 31, 2016 | 35,000.00 |
| Mar 31, 2016 | 35,000.00 |
| Dec 31, 2015 | 54,000.00 |
| Dec 31, 2015 | 54,000.00 |
| Sep 30, 2015 | 38,000.00 |
| Sep 30, 2015 | 38,000.00 |
| Jun 30, 2015 | 37,000.00 |
| Jun 30, 2015 | 37,000.00 |
| Mar 31, 2015 | 37,000.00 |
| Mar 31, 2015 | 37,000.00 |
| Dec 31, 2014 | 37,000.00 |
| Dec 31, 2014 | 37,000.00 |
| Sep 30, 2014 | 41,000.00 |
| Sep 30, 2014 | 41,000.00 |
| Jun 30, 2014 | 19,000.00 |
| Jun 30, 2014 | 19,000.00 |
| Mar 31, 2014 | 6,000.00 |
| Mar 31, 2014 | 6,000.00 |
| Dec 31, 2013 | 18,000.00 |
| Dec 31, 2013 | 18,000.00 |
| Sep 30, 2013 | 10,000.00 |
| Sep 30, 2013 | 10,000.00 |